SULT1C2P1

Across TCGA pan-cancer cohorts, SULT1C2P1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SULT1C2P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SULT1C2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SULT1C2P1 expression acts as an unfavorable survival marker, although some lineages such as READ and STAD show a favorable association.

LIHC, READ, and LUSC are the cancer types where SULT1C2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Quartile	III,IV	0.428	0.775	.001	59	view →
READ	OS	Tertile	All	0.985	0.842	<.001	45	view →
LUSC	DFS	Median	II,III,IV	0.278	0.447	.004	31	view →
KIRP	DFS	Quartile	All	0.332	0.680	.001	24	view →
STAD	OS	Quartile	II,III,IV	0.723	0.358	.004	24	view →
ACC	DFS	Tertile	II,III,IV	0.088	0.606	<.001	18	view →
PRAD	DFS	Median	All	0.881	0.675	<.001	18	view →
LGG	OS	Median	All	0.847	0.955	<.001	17	view →
PCPG	OS	Tertile	All	0.757	0.982	.009	15	view →
ESCA	OS	Median	All	0.617	1.000	.009	12	view →
THCA	OS	Median	III,IV	0.695	0.982	.009	9	view →
KIRC	OS	Tertile	All	0.916	0.825	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SULT1C2P1–LIHC (OS)

Open the LIHC breakdown →